Scarica l'app Stockscreener
240.00
0.20%
-0.49
Pre-mercato:
242.00
2.00
+0.83%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$240.49
Aprire:
$239.02
Volume 24 ore:
1.03M
Relative Volume:
0.49
Capitalizzazione di mercato:
$55.82B
Reddito:
$250.74B
Utile/perdita netta:
$1.55B
Rapporto P/E:
36.70
EPS:
6.5398
Flusso di cassa netto:
$4.39B
1 W Prestazione:
-2.24%
1M Prestazione:
+1.52%
6M Prestazione:
+7.97%
1 anno Prestazione:
+59.00%
Intervallo 1D:
$238.41
$241.64
Intervallo di 1 settimana:
$238.41
$249.29
Portata 52W:
$145.87
$258.30
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
240.00 | 55.93B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
891.68 | 103.66B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
323.32 | 61.96B | 328.68B | 2.55B | 1.56B | 13.03 |
HSIC
Henry Schein Inc
|
87.97 | 9.90B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
0.8001 | 699.76M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Cardinal Health at Wells Fargo conference: specialty growth drives outlook By Investing.com - Investing.com India
Cardinal Health (NYSE:CAH): Is the Story Fully Valued? - Kalkine Media
Cardinal Health stock slips as analysts raise price targets and earnings outlook stays solid - ad-hoc-news.de
Is Cardinal Health (CAH) Fully Valued As It Heads To The Wells Fargo Conference? - simplywall.st
Cardinal Health’s $1.35 Billion Buyback — A Bold Signal Behind Its Capital Strategy! - Smartkarma
Cardinal Health (CAH) Declines More Than Market: Some Information for Investors - Yahoo Finance
Cardinal Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform? - TradingView
Injectable Drug Delivery Market Forecast: USD 1,034.78 Billion by 2030 – MarketsandMarkets™ - Yahoo Finance
Cardinal Health stock gains on strong results and higher targets - AD HOC NEWS
Cardinal Health, Inc. (CAH): Investor Outlook on a Healthcare Giant with a 9.61% Potential Upside - DirectorsTalk Interviews
Nagaraj Bhat Appointed Vice President/GM, Global Capability Center (GCC) Site Leader at DePuy Synthes - hrtoday.in
Cardinal Health stock holds firm as investors digest strong earnings and guidance - ad-hoc-news.de
Is CAH Becoming the Backbone of US Healthcare Infrastructure? - easternprogress.com
Chicago Archbishop Cardinal Blase Cupich, 2 orders of Catholic nuns file lawsuit in effort to block IL medical aid-in-dying law - ABC7 Chicago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - Currently.com
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cencora (COR) Unveils Cell And Gene Therapy Enablement Service - simplywall.st
Cardinal Health leases Sacramento building for 100-job distribution center - The Business Journals
Jim Cramer Makes Bold Cardinal Health (NYSE: CAH) Claim As Specialty Push Drives Earnings Growth - foreignpolicyjournal.com
Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore” - Yahoo Finance
Cardinal Health Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen - Yahoo Finance
Is Generics Still a Quiet Profit Engine for Cardinal Health? - Yahoo Finance
Cardinal Health (CAH) Advances 2.57% to $245.49, Edging Toward Key Resistance at $257.76Risk Reward Setups - dars.gov.et
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health stock gains support from strong cash flow and dividend - AD HOC NEWS
Cardinal Health stock edges higher as investors eye FY 2027 guidance - AD HOC NEWS
Cardinal Health stock holds steady as consensus price targets point higher - AD HOC NEWS
Cardinal Health, Inc. (CAH) - DirectorsTalk Interviews
Precision Trading with Cardinal Health Inc. (CAH) Risk Zones - news.stocktradersdaily.com
Cardinal Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
What Cardinal Health (CAH)'s Bigger Buyback, Dividend and New Credit Line Means For Shareholders - Sahm
Trade Alert: CEO & Director Of Cardinal Health Jason Hollar Has Sold Stock - simplywall.st
The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors - Currently.com
Cardinal Health's CFO Moved $9.9 Million of Stock. Here's What Long-Term Investors Should Know - The Motley Fool
Cardinal Health CEO Sells $29 Million in Stock After Earnings Send Shares to Record - barrons.com
Paralel Advisors LLC Invests $2.60 Million in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Updates Labeling for Leader Dry Eye Relief Eye Drops - geneonline.com
118,900 Shares in Cardinal Health, Inc. $CAH Bought by Ceredex Value Advisors LLC - MarketBeat
Cardinal Health stock holds firm after August 11 earnings - Ad-hoc-news.de
Great Lakes Advisors LLC Makes New $3.65 Million Investment in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health CEO Jason Hollar sells $29.4m in company stock - Investing.com South Africa
Cardinal Health Chief Accounting Officer Mary C. Scherer Sells 2,302 Shares in August 2026 - Kalkine Media
Cardinal Health (NYSE:CAH) CAO Sells 2,302 Shares of Stock - MarketBeat
Cardinal Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Cardinal Health stock holds close to record levels as insider sales and analyst targets frame the ne - Ad-hoc-news.de
Cardinal Health CEO Deborah Weitzman sells $1.73m in shares By Investing.com - Investing.com South Africa
Cardinal Health (CAH) CEO Jason Hollar Sells 124,529 Shares - GuruFocus
Cardinal Health PSS Segment CEO Deborah Weitzman Sells 7,354 Shares in August 2026 Transactions - Kalkine Media
Cardinal Health chief legal officer Jessica Mayer sells $6.95m in stock - Investing.com South Africa
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.42%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):